title: Elevated paracellular glucose flux across cystic fibrosis airway epithelial monolayers is an important factor for Pseudomonas aeruginosa growth.
abstract: People with cystic fibrosis (CF) who develop related diabetes (CFRD) have accelerated pulmonary decline, increased infection with antibiotic-resistant Pseudomonas aeruginosa and increased pulmonary exacerbations. We have previously shown that glucose concentrations are elevated in airway surface liquid (ASL) of people with CF, particularly in those with CFRD. We therefore explored the hypotheses that glucose homeostasis is altered in CF airway epithelia and that elevation of glucose flux into ASL drives increased bacterial growth, with an effect over and above other cystic fibrosis transmembrane conductance regulator (CFTR)-related ASL abnormalities. The aim of this study was to compare the mechanisms governing airway glucose homeostasis in CF and non-CF primary human bronchial epithelial (HBE) monolayers, under normal conditions and in the presence of Ps. aeruginosa filtrate. HBE-bacterial co-cultures were performed in the presence of 5 mM or 15 mM basolateral glucose to investigate how changes in blood glucose, such as those seen in CFRD, affects luminal Ps. aeruginosa growth. Calu-3 cell monolayers were used to evaluate the potential importance of glucose on Ps. aeruginosa growth, in comparison to other hallmarks of the CF ASL, namely mucus hyperviscosity and impaired CFTR-dependent fluid secretions. We show that elevation of basolateral glucose promotes the apical growth of Ps. aeruginosa on CF airway epithelial monolayers more than non-CF monolayers. Ps. aeruginosa secretions elicited more glucose flux across CF airway epithelial monolayers compared to non-CF monolayers which we propose increases glucose availability in ASL for bacterial growth. In addition, elevating basolateral glucose increased Ps. aeruginosa growth over and above any CFTR-dependent effects and the presence or absence of mucus in Calu-3 airway epithelia-bacteria co-cultures. Together these studies highlight the importance of glucose as an additional factor in promoting Ps. aeruginosa growth and respiratory infection in CF disease.
authors.affiliation: Division of Biomedical Sciences, St George's University of London, London, United Kingdom.
authors.forename: James P
authors.initials: JP
authors.lastname: Garnett
authors.forename: Michael A
authors.initials: MA
authors.lastname: Gray
authors.forename: Robert
authors.initials: R
authors.lastname: Tarran
authors.forename: Malcolm
authors.initials: M
authors.lastname: Brodlie
authors.forename: Christopher
authors.initials: C
authors.lastname: Ward
authors.forename: Emma H
authors.initials: EH
authors.lastname: Baker
authors.forename: Deborah L
authors.initials: DL
authors.lastname: Baines
mesh_terms: D045744:Cell Line, Tumor; D002478:Cells, Cultured; D003550:Cystic Fibrosis / Q000378:metabolism*; D005947:Glucose / Q000378:metabolism*; D006801:Humans; D011550:Pseudomonas aeruginosa / Q000472:pathogenicity*; D020545:Respiratory Mucosa / Q000378:metabolism*
chemical_list: D005947:Glucose